Effects of TNF-alpha antagonism on E-selectin in obese subjects with metabolic dysregulation

Clinical Endocrinology

Volumn 73, Issue 1, 2010, Pages 48-54

  Zanni, Markella V ^a   Stanley, Takara L ^a   Makimura, Hideo ^a   Chen, Cindy Y ^a   Grinspoon, Steven K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ETANERCEPT; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; IMMUNOGLOBULIN G; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; BODY COMPOSITION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; METABOLIC PARAMETERS; OBESITY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RANDOMIZED CONTROLLED TRIAL; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; BODY COMPOSITION; E-SELECTIN; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953784676     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2009.03741.x     Document Type: Article

References (35)

1. Ogden, C.L., Carroll, M.D., Curtin, L.R. et al. (2006) Prevalence of overweight and obesity in the United States, 1999-2004. Journal of the American Medical Association, 295, 1549 1555.
2. Uchegbu, E.C. Kopelman, P.G. (2002) Cardiovascular risks in obesity. Journal of Endocrinological Investigation, 25, 915 918.
3. Brunner, E.J., Hemingway, H., Walker, B.R. et al. (2002) Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation, 106, 2659 2665.
4. Festa, A., D'Agostino Jr., R., Howard, G. et al. (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation, 102, 42 47.
5. Yudkin, J.S., Stehouwer, C.D.A., Emeis, J.J. et al. (1999) C-reactive protein in healthy subjects: associations with obesity, insulin resistance and endothelial dysfunction. Arteriosclerosis, Thrombosis, and Vascular Biology, 19, 972 978.
6. Salmon, J.E. Roman, M.J. (2008) Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. American Journal of Medicine, 121, S3 S8.
7. Roman, M.J., Moeller, E., Davis, A. et al. (2006) Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Annals of Internal Medicine, 144, 249 256.
8. Barthel, S.R., Gavino, J.D., Descheny, L. et al. (2007) Targeting selectins and selectin ligands in inflammation and cancer. Expert Opinion on Therapeutic Targets, 11, 1473 1491.
9. Carter, A.M. Grant, P.J. (1997) Vascular homeostasis, adhesion molecules, and macrovascular disease in non-insulin-dependent diabetes mellitus. Diabetic Medicine, 14, 423 432.
10. Haraldsen, G., Kvale, D., Lien, B. et al. (1996) Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells. Journal of Immunology, 156, 2558 2565.
11. Wyble, C.W., Hynes, K.L., Kuchibhotla, J. et al. (1997) TNF-alpha and IL-1 upregulate membrane-bound and soluble E-selectin through a common pathway. Journal of Surgical Research, 73, 107 112.
12. Roldan, V., Marin, F., Lip, G.Y. et al. (2003) Soluble E-selectin in cardiovascular disease and its risk factors. A review of the literature. Journal of Thrombosis and Haemostasis, 90, 1007 1020.
13. Matsumoto, K., Sera, Y., Abe, Y. et al. (2002) High serum concentrations of soluble E-selectin correlate with obesity but not fat distribution in patients with type 2 diabetes mellitus. Metabolism, 51, 932 934.
14. Ferri, C., Desideri, G., Valenti, M. et al. (1999) Early upregulation of endothelial adhesion molecules in obese hypertensive men. Hypertension, 34, 568 573.
15. Bernstein, L.E., Berry, J., Kim, S. et al. (2006) Effects of etanercept in patients with the metabolic syndrome. Archives of Internal Medicine, 166, 902 908.
16. Alberti, K.G. Zimmet, P.Z. (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine, 15, 539 553.
17. Maple, C., Kirk, G., McLaren, M. et al. (1998) A circadian variation exists for soluble levels of intercellular adhesion molecule-1 and E-selectin in healthy volunteers. Clinical Science (London), 94, 537 540.
18. Borkan, G.A., Gerzof, S.G., Robbins, A.H. et al. (1982) Assessment of abdominal fat content by computed tomography. American Journal of Clinical Nutrition, 36, 172 177.
19. Chandrasekharan, U.M., Siemionow, M., Unsal, M. et al. (2007) Tumor necrosis factor alpha (TNF-alpha) receptor-II is required for TNF-alpha-induced leukocyte-endothelial interaction in vivo. Blood, 109, 1938 1944.
20. Pontiroli, A.E., Frige, F., Paganelli, M. et al. (2009) In morbid obesity, metabolic abnormalities and adhesion molecules correlate with visceral fat, not with subcutaneous fat: effect of weight loss through surgery. Obesity Surgery, 19, 745 750.
21. Ito, H., Ohshima, A., Inoue, M. et al. (2002) Weight reduction decreases soluble cellular adhesion molecules in obese women. Clinical and Experimental Pharmacology and Physiology, 29, 399 404.
22. Couillard, C., Ruel, G., Archer, W.R. et al. (2005) Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. Journal of Clinical Endocrinology and Metabolism, 90, 6454 6459.
23. Pontiroli, A.E., Pizzocri, P., Koprivec, D. et al. (2004) Body weight and glucose metabolism have a different effect on circulating levels of ICAM-1, E-selectin, and endothelin-1 in humans. European Journal of Endocrinology, 150, 195 200.
24. Bermudez, E.A., Rifai, N., Buring, J.E. et al. (2002) Relation between markers of systemic vascular inflammation and smoking in women. American Journal of Cardiology, 89, 1117 1119.
25. Lantz, M., Gullberg, U., Nilsson, E. et al. (1990) Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor. Journal of Clinical Investigation, 86, 1396 1402.
26. Lantz, M., Malik, S., Slevin, M.L. et al. (1990) Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans. Cytokine, 2, 402 406.
27. Aderka, D. (1996) The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine and Growth Factor Reviews, 7, 231 240. (Pubitemid 27200307)
28. Cordiali-Fei, P., Trento, E., D'Agosto, G. et al. (2007) Effective therapy with anti-TNF-alpha in patients with psoriatic arthritis is associated with decreased levels of metalloproteinases and angiogenic cytokines in the sera and skin lesions. Annals of the New York Academy of Science, 1110, 578 589.
29. Mastroianni, A., Minutilli, E., Mussi, A. et al. (2005) Cytokine profiles during infliximab monotherapy in psoriatic arthritis. British Journal of Dermatology, 153, 531 536.
30. Lee, W.J., Wu, C.S., Lin, H. et al. (2009) Visfatin-induced expression of inflammatory mediators in human endothelial cells through the NF-kappaB pathway. International Journal of Obesity (Lond), 33, 465 472.
31. Libby, P., Ridker, P.M. Maseri, A. (2002) Inflammation and atherosclerosis. Circulation, 105, 1135 1143.
32. Ross, R. (1999) Atherosclerosis is an inflammatory disease. American Heart Journal, 138, S419 S420.
33. Wenzel, K., Felix, S., Kleber, F.X. et al. (1994) E-selectin polymorphism and atherosclerosis: an association study. Human Molecular Genetics, 3, 1935 1937.
34. Kopp, E. Ghosh, S. (1994) Inhibition of NF-kappa B by sodium salicylate and aspirin [see comments]. Science, 265, 956 959.
35. Fleischman, A., Shoelson, S.E., Bernier, R. et al. (2008) Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care, 31, 289 294.